Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | KDM6B | O15054 | 1/20 | 0.32 |
| ▸ | KDM5C | P41229 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.32 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11743715 | 0.97 | ALDH1A1 (0.37) | ALDH1A1TDP1TRPA1KDM4EKDM6B | |
| SCHEMBL6272633 | 0.97 | ALDH1A1 (0.37) | ALDH1A1TDP1TRPA1KDM4EKDM6B | |
| SCHEMBL2855901 | 0.79 | MGAM (0.39) | ALDH1A1KDM4EKDM6BKDM5CEGLN1 | |
| SCHEMBL10571434 | 0.73 | ALDH1A1 (0.39) | ALDH1A1TDP1TRPA1LMNASLC15A2 | |
| SCHEMBL16662440 | 0.72 | ALDH1A1 (0.44) | ALDH1A1TDP1TRPA1LMNASLC15A2 | |
| SCHEMBL10001246 | 0.71 | ALDH1A1 (0.37) | ALDH1A1TDP1TRPA1LMNASLC15A2 | |
| SCHEMBL13240553 | 0.71 | HMGCR (0.41) | ALDH1A1TDP1TRPA1LMNASLC15A2 | |
| SCHEMBL9015652 | 0.71 | ALDH1A1 (0.37) | ALDH1A1TDP1TRPA1LMNASLC15A2 | |
| SCHEMBL1413211 | 0.69 | LMNA (0.33) | ALDH1A1TDP1KDM4ELMNASLC15A2 | |
| SCHEMBL6910126 | 0.69 | ALDH1A1 (0.41) | ALDH1A1TDP1TRPA1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5311199-A | — | — | None | — | — | JP | disclosed |
| US-20260071299-A1 | APPARATUS AND METHODS FOR RARE EARTH ELEMENT RECOVERY AND PURIFICATION | BATTELLE MEMORIAL INSTITUTE (US) | 2026-03-12 | — | — | US | disclosed |
| CN-109790489-B | Low pH laundry detergent compositions | 宝洁公司 | 2021-06-01 | — | — | CN | disclosed |
| EP-1558620-B1 | RUTHENIUM ANTICANCER COMPLEXES | UNIV EDINBURGH (GB) | 2008-09-10 | — | — | EP | disclosed |
| US-7282573-B2 | Process for making metal acetylacetonates | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-10-16 | — | — | US | disclosed |
| US-20060058270-A1 | Ruthenium anticancer complexes | UNIVERSITY COURT, THE UNIVERSITY OF EDINBURGH (UK), THE (GB) | 2006-03-16 | — | — | US | disclosed |
| WO-2005073341-A1 | DUAL EMITTING DYADS OF HEAVY METAL COMPLEXES AS BROAD BAND EMITTERS FOR ORGANIC LEDS | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2005-08-11 | — | — | WO | disclosed |
| EP-1558620-A1 | RUTHENIUM ANTICANCER COMPLEXES | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2005-08-03 | — | — | EP | disclosed |
| EP-1539168-A2 | TREATMENT OF NEUROPATHIC PAIN WITH 6H-PYRROLO(3,4-D)PYRIDAZINE COMPOUNDS | Merck & Co., Inc. (US) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004056737-A1 | PROCESS FOR THE PREPARATION OF METAL ACETYLACETONATES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-07-08 | — | — | WO | disclosed |
| WO-2004006836-A2 | TREATMENT OF NEUROPATHIC PAIN WITH 6H-PYRROLO[3,4-D]PYRIDAZINE COMPOUNDS | MERCK & CO., INC. (US) | 2004-01-22 | — | — | WO | disclosed |
| WO-2004005304-A1 | RUTHENIUM ANTICANCER COMPLEXES | THE UNIVERSITY COURT, THE UNIVERSITY OF EDINBURGH (GB) | 2004-01-15 | — | — | WO | disclosed |
| WO-2004002942-A1 | METHOD OF PREPARING TETRAACETYLETHYLENEDIAMINE | ZHEJIANG JINKE CHEMISTRY CO., LTD (CN) | 2004-01-08 | — | — | WO | disclosed |
| EP-0630400-A1 | LOW-DOSAGE AUTOMATIC DISHWASHING DETERGENT WITH MONOPERSULFATE AND ENZYMES | THE PROCTER & GAMBLE COMPANY (US) | 1994-12-28 | — | — | EP | disclosed |
| JP-H05311199-A | BLEACHING AGENT COMPOSITION AND BLEACHING DETERGENT COMPOSITION | LION CORP | 1993-11-22 | — | — | JP | disclosed |
| WO-1993018129-A1 | LOW-DOSAGE AUTOMATIC DISHWASHING DETERGENT WITH MONOPERSULFATE AND ENZYMES | THE PROCTER & GAMBLE COMPANY (US) | 1993-09-16 | — | — | WO | disclosed |
| EP-0412697-A2 | N, N'-(1-oxo-1,2-ethanediyl)-bis (aspartic acid), salts and use in detergent compositions | THE PROCTER & GAMBLE COMPANY (US) | 1991-02-13 | — | — | EP | disclosed |
| US-4164518-A | BETA DIKETO COMPLEXES OF PALLADIUM AS CATALYSTS | TEIJIN LIMITED (JP) | 1979-08-14 | — | — | US | disclosed |
| US-3983159-A | Process for producing biphenylpolycarboxylic acid ester | TEIJIN LIMITED (JA) | 1976-09-28 | — | — | US | disclosed |
| US-3966818-A | FROM 2,4,6-TRIMETHYLPHENOL AND OXYGEN | TEIJIN LIMITED (JA) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071299-A1 | APPARATUS AND METHODS FOR RARE EARTH ELEMENT RECOVERY AND PURIFICATION | ERCC4, ERCC2, XPA | ALDH1A1 3727/4885TDP1 1749/4885TRPA1 2087/4885 |
| US-20060058270-A1 | Ruthenium anticancer complexes | TP53, RBBP5, TOP2B | ALDH1A1 1401/4885TDP1 1905/4885TRPA1 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.